Heard of that new pill to treat COVID-19? Here is what you need to know!
Treatments
Sarah Whitley Coles, MD
TL;DR: The FDA gave emergency use authorization to Paxlovid, an antiviral pill, that may reduce the risk of hospitalization and death for people who have mild to moderate COVID-19 infections and are at increased risk of getting severely ill. While this is super exciting news, it is not a magic answer to stopping the pandemic. Read more…
April 4, 2022
📣 Have you heard about the new covid.gov website?
Masks Testing and Contact Tracing Treatments Vaccines
Aparna Kumar, PhD CRNP MPH
Yes! ✋🏾 We have! ✋🏾 It is still early, but it is pretty neat from a nerdy girl standpoint. It helps people get a lot of questions answered in one place. We tried it out and especially thought it was helpful to order free COVID-19 tests and to find COVID-19 treatment once someone receives a Read more…
March 25, 2022
What do you know about that COVID-19 treatment Molnupiravir?
Treatments
Sarah Whitley Coles, MD
Molnupiravir is an antiviral pill that can be used in the treatment of adults with mild to moderate COVID-19 illness who are at high risk of serious illness. It should be taken within 5 days of the first symptom and only when other antiviral treatments are not available. How does molnupiravir work? Get ready for Read more…
March 9, 2022
What is the new COVID “Test to Treat” initiative in the United States?
Testing and Contact Tracing Treatments
Chana Davis, PhD
A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…
February 4, 2022
Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?
Treatments
Ashley Ritter, APRN, PhD
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
January 29, 2022
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
TL;DR: The FDA gave emergency use authorization to Paxlovid, an antiviral pill, that may reduce the risk of hospitalization and death for people who have mild to moderate COVID-19 infections and are at increased risk of getting severely ill. While this is super exciting news, it is not a magic answer to stopping the pandemic. Read more…
📣 Have you heard about the new covid.gov website?
Masks Testing and Contact Tracing Treatments Vaccines
Aparna Kumar, PhD CRNP MPH
Yes! ✋🏾 We have! ✋🏾 It is still early, but it is pretty neat from a nerdy girl standpoint. It helps people get a lot of questions answered in one place. We tried it out and especially thought it was helpful to order free COVID-19 tests and to find COVID-19 treatment once someone receives a Read more…
March 25, 2022
What do you know about that COVID-19 treatment Molnupiravir?
Treatments
Sarah Whitley Coles, MD
Molnupiravir is an antiviral pill that can be used in the treatment of adults with mild to moderate COVID-19 illness who are at high risk of serious illness. It should be taken within 5 days of the first symptom and only when other antiviral treatments are not available. How does molnupiravir work? Get ready for Read more…
March 9, 2022
What is the new COVID “Test to Treat” initiative in the United States?
Testing and Contact Tracing Treatments
Chana Davis, PhD
A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…
February 4, 2022
Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?
Treatments
Ashley Ritter, APRN, PhD
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
January 29, 2022
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Yes! ✋🏾 We have! ✋🏾 It is still early, but it is pretty neat from a nerdy girl standpoint. It helps people get a lot of questions answered in one place. We tried it out and especially thought it was helpful to order free COVID-19 tests and to find COVID-19 treatment once someone receives a Read more…
What do you know about that COVID-19 treatment Molnupiravir?
Treatments
Sarah Whitley Coles, MD
Molnupiravir is an antiviral pill that can be used in the treatment of adults with mild to moderate COVID-19 illness who are at high risk of serious illness. It should be taken within 5 days of the first symptom and only when other antiviral treatments are not available. How does molnupiravir work? Get ready for Read more…
March 9, 2022
What is the new COVID “Test to Treat” initiative in the United States?
Testing and Contact Tracing Treatments
Chana Davis, PhD
A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…
February 4, 2022
Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?
Treatments
Ashley Ritter, APRN, PhD
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
January 29, 2022
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Molnupiravir is an antiviral pill that can be used in the treatment of adults with mild to moderate COVID-19 illness who are at high risk of serious illness. It should be taken within 5 days of the first symptom and only when other antiviral treatments are not available. How does molnupiravir work? Get ready for Read more…
What is the new COVID “Test to Treat” initiative in the United States?
Testing and Contact Tracing Treatments
Chana Davis, PhD
A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…
February 4, 2022
Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?
Treatments
Ashley Ritter, APRN, PhD
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
January 29, 2022
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…
Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?
Treatments
Ashley Ritter, APRN, PhD
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
January 29, 2022
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…
Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).
Treatments Uncertainty and Misinformation
Malia Jones, PhD MPH
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
January 13, 2022
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…
What does it really mean when we talk about “mild” COVID-19 infections?
Clinical Symptoms Treatments
Sarah Whitley Coles, MD
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
January 6, 2022
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
It sure doesn’t feel all that mild… We hear you! Many people who have had a “mild” COVID-19 infection might disagree with that descriptor! There is a lot of talk about mild, moderate, and severe COVID-19 infections, but what does that actually mean? These distinctions have a specific medical meaning and do matter, because they Read more…
What does it mean when hospitals are talking about “Crisis Standards of Care?”
Treatments
Sarah Whitley Coles, MD
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
December 14, 2021
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…
💥 #GoodNewsTues: Clinical Trial Edition! 💥
Treatments
Lindsey Leininger, PhD MA
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
November 24, 2021
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…
Could Luvox help me recover from COVID-19?
Treatments
Aparna Kumar, PhD CRNP MPH
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
November 17, 2021
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
A: Maybe. Maybe not. The evidence is promising, but we still need more information. ⬇️ Read on for the why, what we know, and what we don’t yet know. WHY THIS WORKS? Recently, people have focused on using medications that already exist to help treat people who have COVID-19 and help them get better sooner. Read more…
💥 PFIZER SUBMITS FDA APPLICATION FOR COVID ANTIVIRAL!
Treatments
Lindsey Leininger, PhD MA
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
November 5, 2021
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
Key points: ✔️ Randomized trial data suggest Pfizer’s COVID-19 antiviral pill is safe and efficacious in high-risk unvaccinated populations ✔️ Taken in combo w/a common HIV drug, Pfizer’s antiviral reduces risk of hospitalization or death by 89% over placebo when taken w/in 3 days of onset ✔️ What scientists still want to know: How well Read more…
🔥PFIZER COVID PILL ⬇️ HOSPITALIZATION RISK 89%🔥
Treatments
Lindsey Leininger, PhD MA
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
October 1, 2021
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
TGIF! We now have *TWO* successful COVID antiviral pills likely headed to market ASAP! From Pfizer’s CEO: “Today’s news is a real game-changer in the global efforts to halt the devastation of this pandemic. These data suggest that our oral antiviral candidate, if approved or authorized by regulatory authorities, has the potential to save patients’ Read more…
Breaking news on the treatment front!
Treatments
Lindsey Leininger, PhD MA
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
September 9, 2021
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…
What’s up with monoclonal antibodies for COVID-19 infections?
Treatments
Sarah Whitley Coles, MD
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…
The safety profile for monoclonal antibody treatment is very good. For people with COVID-19 infections who do not need to be hospitalized and who are at high risk of progressing to severe illness, monoclonal antibody therapies can reduce the risk of hospitalization and death. Monoclonal antibody therapies use laboratory made antibodies that are Read more…